Last week, Abhijit Banerjee, Esther Duflo and Michael Kremer accepted the 2019 Nobel Memorial Prize in Economic Sciences. They were recognized for their use of randomized controlled trials, also known ...

The U.S. health care system is often inefficient, ineffective, and inequitable. Compared to other high-income countries, the U.S. pays more for health care and has worse outcomes. One potentially ...

Section 1115 waivers in the Medicaid program are meant to be experiments for states to test coverage approaches that don't meet federal requirements. However, most of those evaluations fall far short, ...

Pomeranz, Dina. "Impact Evaluation Methods in Public Economics: A Brief Introduction to Randomized Evaluations and Comparison with Other Methods." Special Issue on Expanding the Frontier of Behavioral ...

Editor’s note: This story was first published on Econofact. The Nobel Memorial prize in Economic Sciences awarded this year to Abhijit Banerjee, Esther Duflo, and Michael Kremer has focused attention ...

In 2013, the president of Rwanda asked us for evaluation results from across the continent that could provide lessons for his country’s policy decisions. One program tested in Kenya jumped out, and ...

A Randomized, Double-Blind, Placebo-Controlled, Phase III Study to Assess Efficacy and Safety of Weekly Farletuzumab in Combination With Carboplatin and Taxane in Patients With Ovarian Cancer in First ...

Although we support Lisbeth B. Schorr’s call for a variety of evaluation methods to identify promising social programs (“Innovative Reforms Require Innovative Scorekeeping,” Aug. 26, 2009.), we ...

HER2-enriched subtype and ERBB2 mRNA as predictors of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer: A combined ...